medi-cal glp-1 coverage The evolving landscape of anti-obesity medication in Medicaid GLP-1 Coverage Cut Widens Health

A few commenters recommended that CMS ensure the repository is a neutral clearinghouse and, if CMS engages with a third-party to operate the repository, that the party is free of conflicts of interest

In an experiment conducted by Petersen et al., 2018, the authors demonstrated that, in mice fed a standard diet but with the elimination of liver-specific phosphatase and the tensin homology (PTEN) (PTENLKO), the animals had more steatosis and hepatic fibrosis compared with the controls

Provenance and peer review Not commissioned, externally peer reviewed

That is where the form matters

Still, the strength of Mounjaro and Zepbound remains impressive, and investors have taken notice